Giuseppe Lazzarino

Professor of Biochemistry [BIO/10]
Membership Section: Medical Biochemistry
Office: Torre Biologica - 2° Piano Torre Est - Stanza 53
Email: lazzarig@unict.it
Phone: 0954781171‬




Prof. Giuseppe Lazzarino has received his Degree in Biological Sciences at the State University of Rome "La Sapienza", Rome, Italy in 1979. In 1980 he joined an Italian pharmaceutical company, becoming head of the Biochemistry and Pharmacology Research Laboratory. In 1986 he became Researcher in Biochemistry at the University of Rome "Tor Vergata", Rome, Italy. Since 1994 he is Full Professor of Biochemistry at the School of Biology of the University of Catania, Catania, Italy (Department of Biomedical and Biotechnological Sciences, Division of Medical Biochemistry). During his career he collaborated with different national and international research groups carrying out research projects of common interest. Since the end of 2010 he established a spin-off company mainly aimed to evidence biochemical markers of clinical interests and to develop proper diagnostic kits, particularly dedicated to male infertility and neurodegenerations (multiple sclerosis), as well as to perform metabolic screenings of biological fluids for prenatal and postnatal diagnosis of IEM. He authored more than 130 papers (Scopus) in the field of biochemistry and, mostly, in translational medicine (neurotraumatology, cardiology, neurodegeneration, male infertility). He holds 8 patents.


view the publications
N.B. the number of publications can affect the loading time of the information
ACADEMIC YEAR 2019/2020


ACADEMIC YEAR 2018/2019


ACADEMIC YEAR 2017/2018


ACADEMIC YEAR 2016/2017


ACADEMIC YEAR 2015/2016

Biochemistry, clinical biochemistry and translational medicine are the main areas of interest in our laboratory. In particular, we are interested in studying: 1) energy metabolism and free radical damage in animals and human beings; 2) biochemical and molecular mechanisms of cell damages in traumatic brain injury; 3) biochemical markers of clinical relevance in acute and chronic neurodegenerations; 4) set up of analytical methods for low molecular weight compounds in biological samples; 5) biochemical and molecular evaluation of IEM (inborn errors of metabolism).